Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

581
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
581
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

441
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
441
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

1.1K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

618
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
618
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

407
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left atrial appendage exclusion during open cardiac surgery in patients without atrial fibrillation reduces 4-year ischemic stroke and mortality.

JTCVS structural and endovascular·2026
Same author

Long-term durability of bioprosthetic aortic valve replacement in young patients with bicuspid aortic stenosis.

JTCVS structural and endovascular·2026
Same author

Embolized transcatheter aortic valve lodges "upside-down" in the proximal aortic arch.

JTCVS structural and endovascular·2026
Same author

Left and Right Heart Remodelling at 1 Year After Transcatheter Versus Surgical Aortic Valve Replacement: A Speckle-Tracking Echocardiography Study.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Postoperative 4-chamber cardiac function and outcomes following biatrial or left atrial Maze procedure for concomitant atrial fibrillation.

JTCVS open·2026
Same author

Do Outcomes After Cardiac Surgery Differ by Preoperative Status and Socioeconomic Deprivation?

Annals of thoracic surgery short reports·2026

Related Experiment Video

Updated: Apr 23, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K

Mortality while waiting for aortic valve replacement.

S Chris Malaisrie1, Eileen McDonald1, Jane Kruse1

  • 1Bluhm Cardiovascular Institute, Division of Cardiac Surgery at Northwestern University, Feinberg School of Medicine and Northwestern Memorial Hospital, Chicago, Illinois.

The Annals of Thoracic Surgery
|September 22, 2014
PubMed
Summary
This summary is machine-generated.

Patients awaiting aortic valve replacement (AVR) face significant mortality risks, especially with prolonged waits. Prompt AVR intervention is crucial for improving survival outcomes in severe symptomatic aortic stenosis.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

10.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

10.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

10.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

10.9K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Severe symptomatic aortic stenosis (AS) carries a high mortality risk without intervention.
  • The impact of waiting times for aortic valve replacement (AVR) on patient outcomes remains underreported.

Purpose of the Study:

  • To evaluate the association between waiting time for AVR and patient survival.
  • To compare mortality risks associated with different AVR waiting times and intervention methods.

Main Methods:

  • Retrospective analysis of 1,005 patients with severe symptomatic AS from 2008-2012.
  • Modeling overall survival using Cox and multistate models based on AVR recommendation and intervention dates.
  • Comparison of outcomes between patients who underwent AVR and those who did not, and between surgical AVR (SAVR) and transcatheter AVR (TAVR).

Main Results:

  • Waiting time for AVR was a median of 2.9 weeks; mortality was significantly lower in the AVR group compared to the non-AVR group.
  • Thirty-day mortality post-AVR was 3.9% (3.2% SAVR, 7.0% TAVR), with no increased mortality linked to waiting time in patients who received AVR.
  • Mortality while waiting for AVR was substantial (3.7% at 1 month, 11.6% at 6 months), with higher waiting mortality for TAVR than SAVR.

Conclusions:

  • Prolonged waiting times for AVR are associated with mortality exceeding operative risks.
  • While waiting time did not negatively impact operative outcomes, many patients may die before AVR.
  • AVR for severe symptomatic AS should be considered semi-urgent rather than elective to mitigate waiting-related mortality.